Translating Germline Cancer Risk into Precision Prevention

Cell

Volumn 168, Issue 4, 2017, Pages 566-570

  Yurgelun, Matthew B ^a   Chenevix Trench, Georgia ^b   Lippman, Scott M ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; GENETIC SCREENING; GENOME-WIDE ASSOCIATION STUDY; GERMLINE MUTATION; HEREDITARY TUMOR; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR GENE; ANIMAL; GENETIC PREDISPOSITION; GENETICS; NEOPLASMS; PERSONALIZED MEDICINE; PROCEDURES;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; NEOPLASMS; PRECISION MEDICINE;

EID: 85012118567     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.01.031     Document Type: Note

References (15)

1. Belcheva, A., Irrazabal, T., Robertson, S.J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E.H., Copeland, J.K., Kumar, S., Green, B., et al. Cell 158 (2014), 288–299.
2. Connor, A.A., Denroche, R.E., Jang, G.H., Timms, L., Kalimuthu, S.N., Selander, I., McPherson, T., Wilson, G.W., Chan-Seng-Yue, M.A., Borozan, I., et al. JAMA Oncol., 2016 Published online October 20, 2016.
3. Communal, L., Vilasco, M., Hugon-Rodin, J., Courtin, A., Mourra, N., Lahlou, N., Le Guillou, M., Perrault de Jotemps, M., Chauvet, M.P., Chaouat, M., et al. Oncotarget 7 (2016), 45317–45330.
4. Dunning, A.M., Michailidou, K., Kuchenbaecker, K.B., Thompson, D., French, J.D., Beesley, J., Healey, C.S., Kar, S., Pooley, K.A., Lopez-Knowles, E., et al. EMBRACE GEMO Study Collaborators HEBON, kConFab Investigators. Nat. Genet. 48 (2016), 374–386.
5. Kotsopoulos, J., Huzarski, T., Gronwald, J., Singer, C.F., Moller, P., Lynch, H.T., Armel, S., Karlan, B., Foulkes, W.D., Neuhausen, S.L., et al., Hereditary Breast Cancer Clinical Study Group. J. Natl. Cancer Inst., 109, 2016.
6. Kuchenbaecker, K.B., McGuffog, L., Barrowdale, D., Lee, A., Soucy, P., Healey, S., Dennis, J., Lush, M., Robson, M., and Spurdle, A.B., et al. (in press) J. Natl. Cancer Inst.
7. Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., Milne, R.L., Schmidt, M.K., Chang-Claude, J., Bojesen, S.E., Bolla, M.K., et al. Nat. Genet. 45 (2013), 353–361.
8. Milne, R.L., Antoniou, A.C., Endocr. Relat. Cancer 23 (2016), T69–T84.
9. Montrose, D.C., Zhou, X.K., McNally, E.M., Sue, E., Yantiss, R.K., Gross, S.S., Leve, N.D., Karoly, E.D., Suen, C.S., Ling, L., et al. Cancer Prev. Res. (Phila.) 9 (2016), 721–731.
10. Nelson, M.R., Tipney, H., Painter, J.L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P.C., Li, M.J., Wang, J., et al. Nat. Genet. 47 (2015), 856–860.
11. Nolan, E., Vaillant, F., Branstetter, D., Pal, B., Giner, G., Whitehead, L., Lok, S.W., Mann, G.B., Rohrbach, K., Huang, L.Y., et al., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Nat. Med. 22 (2016), 933–939.
12. Salo-Mullen, E.E., O'Reilly, E.M., Kelsen, D.P., Ashraf, A.M., Lowery, M.A., Yu, K.H., Reidy, D.L., Epstein, A.S., Lincoln, A., Saldia, A., et al. Cancer 121 (2015), 4382–4388.
13. Spira, A., Disis, M.L., Schiller, J.T., Vilar, E., Rebbeck, T.R., Bejar, R., Ideker, T., Arts, J., Yurgelun, M.B., Mesirov, J.P., et al. Proc. Natl. Acad. Sci. USA 113 (2016), 10750–10758.
14. Vasen, H., Ibrahim, I., Ponce, C.G., Slater, E.P., Matthäi, E., Carrato, A., Earl, J., Robbers, K., van Mil, A.M., Potjer, T., et al. J. Clin. Oncol. 34 (2016), 2010–2019.
15. Yurgelun, M.B., Kulke, M.H., Fuchs, C.S., Allen, B.A., Uno, H., Hornick, J.L., Ukaegbu, C.I., Brais, L.K., McNamara, P.G., Mayer, R.J., et al. J. Clin. Oncol., 2017, 10.1200/JCO.2016.71.0012 Published online January 30, 2017.